Bankrupt biotech Bind eyes $20 million sale to Pfizer - FierceBiotec...
07/07/16
![]()
Bankrupt biotech Bind eyes $20 million sale to Pfizer
FierceBiotech
The company, which in April axed nearly 40% of its staff and filed for bankruptcy just a week later, is set to sell nearly all of its assets in a court-supervised deal to the New York Big Pharma for just under $20 million in cash--with Pfizer also ...
BIND Therapeutics Files Motion for Sale of Assets After Accepting Stalking Horse Bid from PfizerPharmaceutical Processing
all 32 news articles »
[more]
FierceBiotech
The company, which in April axed nearly 40% of its staff and filed for bankruptcy just a week later, is set to sell nearly all of its assets in a court-supervised deal to the New York Big Pharma for just under $20 million in cash--with Pfizer also ...
BIND Therapeutics Files Motion for Sale of Assets After Accepting Stalking Horse Bid from PfizerPharmaceutical Processing
all 32 news articles »